Polymeric nanoparticles—Tools in a drug delivery system in selected cancer therapies

M Madej, N Kurowska, B Strzalka-Mrozik - Applied Sciences, 2022 - mdpi.com
The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

Three Strategies in Engineering Nanomedicines for Tumor Microenvironment‐Enabled Phototherapy

S He, X Jia, S Feng, J Hu - Small, 2023 - Wiley Online Library
Canonical phototherapeutics have several limitations, including a lack of tumor selectivity,
nondiscriminatory phototoxicity, and tumor hypoxia aggravation. The tumor …

Novel 1, 4-dihydropyridines as specific binders and activators of SIRT3 impair cell viability and clonogenicity and downregulate hypoxia-induced targets in cancer …

C Zwergel, M Aventaggiato, S Garbo… - Journal of Medicinal …, 2023 - ACS Publications
The mitochondrial SIRT3 modulates several biological pathways such as cancer,
metabolism, and hypoxia-related diseases. Recently, we discovered new 1, 4 …

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies

S Zheng, W Wang, L Shen, Y Yao, W Xia… - … Hematology & Oncology, 2024 - Springer
The tumor microenvironment demonstrates great immunophenotypic heterogeneity, which
has been leveraged in traditional immune-hot/cold tumor categorization based on the …

[HTML][HTML] Decoding the role of insulin-like growth factor 1 and its isoforms in breast cancer

A Kotsifaki, S Maroulaki, E Karalexis… - … journal of molecular …, 2024 - pmc.ncbi.nlm.nih.gov
Insulin-like Growth Factor-1 (IGF-1) is a crucial mitogenic factor with important functions in
the mammary gland, mainly through its interaction with the IGF-1 receptor (IGF-1R). This …

[HTML][HTML] Azithromycin delivery via polymeric and non-polymeric nanoparticle systems: Expanding frontiers in cancer therapy

M Pourmadadi, S Tokasi, S Fathi-karkan… - European Polymer …, 2024 - Elsevier
Cancer treatment demands innovative approaches. Azithromycin (AZM), traditionally an
antibiotic, shows promise in inhibiting cancer growth due to its anti-inflammatory and …

Beyond aromatherapy: can essential oil loaded nanocarriers revolutionize cancer treatment?

OAA Alabrahim, JM Lababidi, W Fritzsche… - Nanoscale …, 2024 - pubs.rsc.org
Cancer, a complex global health burden, necessitates the development of innovative
therapeutic strategies. While chemotherapy remains the primary treatment approach, its …

Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment

X Guo, R Sui, H Piao - CNS Neuroscience & Therapeutics, 2023 - Wiley Online Library
Gliomas are the most common primary malignant tumors in the central nervous system.
However, conventional treatments, such as surgical resection and postoperative combined …

[HTML][HTML] Factors determining epithelial-mesenchymal transition in cancer progression

P Tomecka, D Kunachowicz, J Górczyńska… - International Journal of …, 2024 - mdpi.com
Epithelial-mesenchymal transition (EMT) is a process in which an epithelial cell undergoes
multiple modifications, acquiring both morphological and functional characteristics of a …

[HTML][HTML] Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation

B Chen, MT Diallo, Y Ma, W Yu, Q Yao, S Gao… - Translational …, 2024 - Elsevier
Background It has been reported that the human family with sequence similarity 198,
member B (Fam198b) play an important role in the occurrence and development of various …